Literature DB >> 21036514

Outpatient versus inpatient opioid detoxification: a randomized controlled trial.

Ed Day1, John Strang.   

Abstract

Opioid detoxification is not an effective stand-alone treatment for heroin dependence but is nevertheless an essential step in the path to recovery. There has been relatively little previous controlled research on the impact of treatment setting on the likelihood of successful completion of detoxification. In this study, 68 opioid-dependent patients receiving community treatment (predominantly with methadone) and requesting detoxification were randomly assigned to an inpatient versus outpatient setting. Both groups received the same medication (lofexidine), and the primary outcome measure was being opioid-free at detoxification completion. More inpatients (n = 18, 51.4%) than outpatients (n = 12, 36.4%) completed detoxification, but this difference was not statistically significant (χ(2) = 1.56, p = .21). However, the outpatient group received a significantly longer period of medication, and when the length of detoxification was controlled for, the results favored the inpatient setting (Exp(B) = 13.9, 95% confidence interval = 2.6-75.5, p = .002). Only 11 (16%) participants were opioid-free at the 1-month follow-up and 8 at the 6-month follow-up, with no between-group difference. Inpatient and outpatient opioid detoxification settings were not significantly different in completion or follow-up abstinence rates, but aspects of the study design may have favored the outpatient setting. Future studies should test patient characteristics that predict better outcomes in each setting.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036514     DOI: 10.1016/j.jsat.2010.08.007

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  14 in total

1.  Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone.

Authors:  Lesia M Ruglass; Jennifer Scodes; Martina Pavlicova; Aimee N C Campbell; Skye Fitzpatrick; Celestina Barbosa-Leiker; Kathleen Burlew; Shelly F Greenfield; John Rotrosen; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2019-10-21       Impact factor: 4.492

2.  Implicit and explicit drug-related cognitions during detoxification treatment are associated with drug relapse: an ecological momentary assessment study.

Authors:  Reshmi Marhe; Andrew J Waters; Ben J M van de Wetering; Ingmar H A Franken
Journal:  J Consult Clin Psychol       Date:  2012-12-10

3.  Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.

Authors:  Christine Timko; Maureen Below; Lisa Vittorio; Emmeline Taylor; Grace Chang; Steven Lash; Fe Erlita D Festin; Deborah Brief
Journal:  J Subst Abuse Treat       Date:  2019-01-04

4.  Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials.

Authors:  Matisyahu Shulman; Mei-Chen Hu; Maria A Sullivan; Sarah C Akerman; James Fratantonio; Vincent Barbieri; Edward V Nunes; Adam Bisaga
Journal:  Drug Alcohol Depend       Date:  2022-02-02       Impact factor: 4.492

Review 5.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03

6.  A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.

Authors:  Mohammad Sibai; Kaitlyn Mishlen; Edward V Nunes; Frances R Levin; John J Mariani; Adam Bisaga
Journal:  Am J Drug Alcohol Abuse       Date:  2019-12-20       Impact factor: 3.829

Review 7.  The clinical relevance of neurocognitive measures in addiction.

Authors:  Reshmi Marhe; Maartje Luijten; Ingmar H A Franken
Journal:  Front Psychiatry       Date:  2014-01-10       Impact factor: 4.157

Review 8.  The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review.

Authors:  MahmoudReza Khansari; MasourReza Sohrabi; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2013-01

9.  Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms.

Authors:  Stacey L McCallum; Jane M Andrews; Matthew D Gaughwin; Deborah A Turnbull; Antonina A Mikocka-Walus
Journal:  Patient Prefer Adherence       Date:  2016-08-04       Impact factor: 2.711

Review 10.  Randomised trials comparing different healthcare settings: an exploratory review of the impact of pre-trial preferences on participation, and discussion of other methodological challenges.

Authors:  Mark S Corbett; Judith Watson; Alison Eastwood
Journal:  BMC Health Serv Res       Date:  2016-10-19       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.